Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Immunotherapy in Melanoma

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Immunotherapy in Melanoma

New Data Establish Long-Term Efficacy for 2 Modern Modalities in NSCLC and Melanoma

For nearly a decade, immunotherapy and molecularly targeted agents have been the focus of intense development. Now emerging evidence suggests that both modalities can deliver long-term benefits for patients, but the findings may prompt additional questions...
Read More >>

Merkel Cell Carcinoma Study Matches TMB With Disease Drivers

Evolutionary Approach Drives Melanoma Advancements

EU Panel Recommends 4-Week Nivolumab Dosing Schedule in Adjuvant Melanoma

Neoadjuvant and Frontline Studies Guide Malignant Melanoma Treatment

An Instinct for Innovation Drives Robert's Melanoma Research

View More Stories >>

View Conference Coverage

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

2019 World Conference on Lung Cancer

Dr. Atkins on Long-Term Outcomes of the CheckMate-204 Trial in Melanoma

Dr. Long on Nivolumab/Ipilimumab in Patients With Melanoma Who Have Brain Mets

Dr. Weber on Rationale for the CheckMate-238 Trial in Melanoma

Dr. Nathan on Long-Term Outcomes With Dabrafenib/Trametinib in <em>BRAF</em> V600-Mutant Melanoma

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Checkpoint Inhibitors in Second and Third-line

Unmet Needs and Future Treatments of Metastatic Melanoma

The Use of Dual Targeted Therapy in Metastatic Melanoma

$Management of Relapsed/Refractory Metastatic Melanoma$

Immunotherapy vs TKIs in BRAF+ Metastatic Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Emerging Treatment Strategies for Advanced BRAF+ Melanoma

Sequencing Therapy in Metastatic BRAF+ Melanoma

Selecting Therapy & Managing Patients With BRAF+ Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Metastatic Melanoma: The New Millennium

Keith Flaherty, MD, moderates this discussion with Rene Gonzalez, MD, Jason Luke, MD, FACP, and Jeffrey Weber, MD, PhD. The panel of experts in melanoma research and treatment talk about the most recent advances in the field, and provide perspective on how to apply the newest data to individualize treatment strategies.

View Now

Dr. Hodi on Long-Term Survival Data for Nivolumab in Melanoma

F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, and investigator at the Ludwig Center at Harvard, discusses the results of a 5-year follow-up analysis of survival outcomes of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More